Funder
The European Research Council
Spanish Ministry of Economy-Competitiveness
Asociación Española Contra el Cáncer, the ISCIII/FEDER
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Reference100 articles.
1. Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, Chen Z, Cimino G, Cordoba JC, Gu LJ, Hussein H, Ishii E, Kamel AM, Labra S, Magalhaes IQ, Mizutani S, Petridou E, de Oliveira MP, Yuen P, Wiemels JL, Greaves MF (2001) Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 61(6):2542–2546
2. Andersson AK, Ma J, Wang J, St. Jude Children’s Research Hospital and Washington University Pediatric Cancer Genome Project et al (2015) The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nat Genet 47(4):330–337. doi: 10.1038/ng.3230
3. Azarova AM, Lin RK, Tsai YC, Liu LF, Lin CP, Lyu YL (2010) Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia. Biochem Biophys Res Commun 399(1):66–71. doi: 10.1016/j.bbrc.2010.07.043
4. Ballabio E, Milne TA (2012) Molecular and epigenetic mechanisms of MLL in human leukemogenesis. Cancers (Basel). 4(3):904–944. doi: 10.3390/cancers4030904
5. Ballabio E, Milne TA (2014) Epigenetic control of gene expression in leukemogenesis: cooperation between wild type MLL and MLL fusion proteins. Mol Cell Oncol. 1(2):e955330. doi: 10.1080/23723548.2014.955330
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献